Friday, February 3, 2023

Latest:

Philosophy, an ancient practice with modern appeal? The role of “big” questions in medical decision-making
Sensitive, rapid tests help to ID estrogen-disrupting chemicals in the environment
Why women with heart issues are undertreated and have worse outcomes than men
Breakthrough epigenetic study can improve the power to predict disease risk
When visible meets invisible: the importance of psychological screening and intervention in pediatric dermatology

Baylor College of Medicine Blog Network

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

RNA splicing

From The Labs

Study of spliceosome-targeting cancer therapies reveals an overlooked role of mis-spliced RNAs themselves

January 19, 2021January 19, 2021apoptosis, cancer treatment, Immunotherapy, Research, RNA splicing, Spliceosome-targeting therapies, triple-negative breast cancer

Endogenous mis-spliced RNA in tumor cells mimics an RNA virus, leading tumor cells to self-destruct as if fighting an infection.

From The Labs

Image of the Month: What causes myotonic dystrophy, type1

September 5, 2017alternative splicing, CELF1 and MBNL proteins, CTG repeat, CUGexp, DM1, DMPK gene, MEF2 transcription factor, muscular dystrophy, myotonic dystrophy, RNA splicing

Myotonic dystrophy, type 1 (DM1) is the second most common cause of muscular dystrophy and numerous other muscle disorders that affect tens of thousands of

From the Labs: Adult-born neurons made the cover